Results 1 to 10 of about 1,308,546 (203)
Invasive Pulmonary Aspergillosis
Journal of Fungi, 2023 Invasive pulmonary aspergillosis is growing in incidence, as patients at risk are growing in diversity. Outside the classical context of neutropenia, new risk factors are emerging or newly identified, such as new anticancer drugs, viral pneumonias and ...
Marie-Pierre Ledoux, Raoul Herbrecht
doaj +5 more sources
Mechanistic Basis of Super-Infection: Influenza-Associated Invasive Pulmonary Aspergillosis
Journal of Fungi, 2022 Influenza infection is a risk factor for invasive pulmonary aspergillosis in both immunocompetent and immunocompromised hosts. The purpose of this review is to highlight the epidemiology of influenza-associated invasive pulmonary aspergillosis and the ...
Keven Mara Robinson
doaj +4 more sources
Subacute invasive pulmonary aspergillosis
Journal of Advanced Lung Health, 2021 Subacute invasive pulmonary aspergillosis (IPA) is an indolent cavitating infectious process which can mimic other chronic lung infections such as tuberculosis.
Ravindran Chetambath
doaj +3 more sources
Invasive pulmonary mucormycosis and aspergillosis in a patient with decompensated hepatic cirrhosis [PDF]
Medical Mycology Case Reports, 2018 Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in non-cirrhotic patients with diabetes mellitus, neutropenia, or treatment with corticosteroids.
Jon G. Persichino +4 more
doaj +2 more sources
TOO MANY MOULDY JOINTS – MARIJUANA AND CHRONIC PULMONARY ASPERGILLOSIS
Mediterranean Journal of Hematology and Infectious Diseases, 2011 Chronic pulmonary aspergillosis is a progressive debilitating disease with multiple underlying pulmonary diseases described. Here we report the association of chronic pulmonary aspergillosis and long term marijuana smoking in 2 patients and review the ...
Youssef Gargani +2 more
doaj +4 more sources
A case of invasive pulmonary aspergillosis during treatment for acute exacerbation of interstitial lung disease [PDF]
Infectious Disease Reports, 2018 Prolonged immunosuppressive therapy is a risk factor for invasive pulmonary aspergillosis. We report a case of a 79-yearold man who underwent immunosuppressive therapy with methylprednisolone and cyclosporine for an acute exacerbation of interstitial ...
Motoi Ugajin, Hisanori Kani
doaj +2 more sources
Invasive pulmonary aspergillosis complicating allergic bronchopulmonary aspergillosis
Respiratory Medicine, 1995 Invasive pulmonary aspergillosis is a frequent complication in immunocompromised patients. The role of the prolonged use of steroids in predisposing to invasive aspergillosis has been recognized, but exceptionally described in asthmatic patients. We report the case of a 59-year-old woman with bronchial asthma treated with steroid therapy for a long ...
A. Ganassini, CAZZADORI, Angelo Antonio
openaire +4 more sources
Rare concurrent invasive pulmonary aspergillosis in a critically Ill patient with hemorrhagic fever with renal syndrome: a case report [PDF]
BMC Infectious DiseasesBackground Hantavirus infection frequently results in hemorrhagic fever with renal syndrome, which may be fatal in certain instances. invasive pulmonary aspergillosis is a rare concurrent symptom that requires considerable attention from clinicians. Case
Weiwei Yan +4 more
doaj +2 more sources
Pediatric Pulmonary and Thoracic Aspergillosis
Siriraj Medical Journal, 2020 Aspergillus infection can cause significant disease in an immunocompromised host and lungs are the most common site of infection. Various forms of aspergillus involving lung parenchyma have been described including aspergilloma, allergic bronchopulmonary
Preeyacha Pacharn +3 more
doaj +1 more source
BMC Infectious Diseases, 2022 Background Kodamaea ohmeri is a rare pathogen with high mortality and is found among blood samples in a considerable proportion; however, gastrointestinal infection of K. ohmeri is extremely rare.
Zi-Mu Li +9 more
doaj +2 more sources